This Biotech Is Already Using AI

This Biotech Is Already Using AI

Source: 
Motley Fool
snippet: 
  • Ginkgo Bioworks is looking for ways to streamline its cellular engineering processes.
  • So far, using AI hasn't been enough to make its business profitable.
  • Improvements to its margins could lead it to become a must-buy biotech stock.